A detailed history of Gw&K Investment Management, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Gw&K Investment Management, LLC holds 1,238,015 shares of SUPN stock, worth $44.1 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
1,238,015
Previous 1,293,315 4.28%
Holding current value
$44.1 Million
Previous $34.6 Million 11.58%
% of portfolio
0.33%
Previous 0.32%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$25.77 - $35.16 $1.43 Million - $1.94 Million
-55,300 Reduced 4.28%
1,238,015 $38.6 Million
Q2 2024

Aug 12, 2024

SELL
$25.99 - $33.85 $1.2 Million - $1.56 Million
-46,127 Reduced 3.44%
1,293,315 $34.6 Million
Q1 2024

May 08, 2024

BUY
$27.11 - $35.17 $594,142 - $770,785
21,916 Added 1.66%
1,339,442 $45.7 Million
Q4 2023

Feb 09, 2024

SELL
$22.72 - $29.68 $2.01 Million - $2.63 Million
-88,632 Reduced 6.3%
1,317,526 $38.1 Million
Q3 2023

Nov 09, 2023

BUY
$27.57 - $32.91 $190,315 - $227,177
6,903 Added 0.49%
1,406,158 $38.8 Million
Q2 2023

Aug 09, 2023

SELL
$29.91 - $38.73 $503,953 - $652,561
-16,849 Reduced 1.19%
1,399,255 $42.1 Million
Q1 2023

May 09, 2023

BUY
$34.93 - $42.03 $334,489 - $402,479
9,576 Added 0.68%
1,416,104 $51.3 Million
Q4 2022

Feb 10, 2023

SELL
$31.09 - $37.88 $11.2 Million - $13.7 Million
-360,961 Reduced 20.42%
1,406,528 $50.2 Million
Q3 2022

Nov 09, 2022

SELL
$28.79 - $35.41 $4.1 Million - $5.04 Million
-142,360 Reduced 7.45%
1,767,489 $59.8 Million
Q2 2022

Aug 09, 2022

BUY
$25.33 - $34.25 $2.1 Million - $2.83 Million
82,758 Added 4.53%
1,909,849 $55.2 Million
Q1 2022

May 09, 2022

SELL
$28.51 - $32.9 $267,281 - $308,437
-9,375 Reduced 0.51%
1,827,091 $59.1 Million
Q4 2021

Feb 11, 2022

BUY
$26.37 - $34.22 $5.56 Million - $7.22 Million
210,976 Added 12.98%
1,836,466 $53.6 Million
Q3 2021

Nov 10, 2021

BUY
$23.54 - $31.39 $221,040 - $294,752
9,390 Added 0.58%
1,625,490 $43.4 Million
Q2 2021

Aug 10, 2021

BUY
$26.72 - $33.19 $1.14 Million - $1.42 Million
42,689 Added 2.71%
1,616,100 $49.8 Million
Q1 2021

May 11, 2021

BUY
$24.15 - $31.45 $6.18 Million - $8.05 Million
256,071 Added 19.44%
1,573,411 $41.2 Million
Q4 2020

Feb 05, 2021

BUY
$17.7 - $25.81 $4.73 Million - $6.9 Million
267,452 Added 25.47%
1,317,340 $33.1 Million
Q3 2020

Nov 10, 2020

BUY
$20.2 - $25.05 $5.23 Million - $6.49 Million
259,087 Added 32.76%
1,049,888 $21.9 Million
Q2 2020

Aug 06, 2020

BUY
$17.09 - $24.89 $13.5 Million - $19.7 Million
790,801 New
790,801 $18.8 Million

Others Institutions Holding SUPN

About SUPERNUS PHARMACEUTICALS, INC.


  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.9B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Gw&K Investment Management, LLC Portfolio

Follow Gw&K Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gw&K Investment Management, LLC with notifications on news.